Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY – Get Free Report) shares dropped 0.8% during trading on Friday . The company traded as low as $3.73 and last traded at $3.81. Approximately 344,637 shares were traded during trading, an increase of 66% from the average daily volume of 207,742 shares. The stock had previously closed at $3.84.
Ono Pharmaceutical Price Performance
The company has a 50-day moving average price of $4.13 and a two-hundred day moving average price of $4.49.
Ono Pharmaceutical Company Profile
Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.
Featured Articles
- Five stocks we like better than Ono Pharmaceutical
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- What’s Behind These 3 Recent Analyst Stock Upgrades?
- Breakout Stocks: What They Are and How to Identify Them
- Fast-Growing Companies That Are Still Undervalued
- NYSE Stocks Give Investors a Variety of Quality OptionsÂ
- Top Cybersecurity Stock Picks for 2025
Receive News & Ratings for Ono Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ono Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
